Literature DB >> 16596307

Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark.

Johnni Hansen1.   

Abstract

Breast cancer is the most frequent cancer among women, and the number is increasing worldwide. This tumour is strongly associated with Western lifestyle, but the specific risk factors behind this observation are not well known. Exposure to light-at-night, including disturbance of the circadian rhythm, possibly mediated via the melatonin synthesis and clock genes, has been suggested as a contributing cause of breast cancer. Since shift- and night-time work is prevalent and increasing in modern societies, this exposure may be of public health concern, and contribute to the continuing elevation in breast cancer risk. Until now only few epidemiological studies have evaluated breast cancer risk after shift and night work. Although these studies are all suffering from methodological problems, especially concerning assessment of light exposure, results have consistently shown an increase in risk associated with night and shift work. Good opportunities for epidemiological cancer research exist in Denmark, and several studies on different aspects of breast cancer, work schedules, light exposure and melatonin levels are ongoing in order to further examine different aspects of this issue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596307     DOI: 10.1007/s10552-005-9006-5

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  39 in total

1.  Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes.

Authors:  Stefano Rossetti; Joseph Esposito; Francesca Corlazzoli; Alex Gregorski; Nicoletta Sacchi
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

2.  Identification of an estrogen-regulated circadian mechanism necessary for breast acinar morphogenesis.

Authors:  Stefano Rossetti; Francesca Corlazzoli; Alex Gregorski; Nurul Hidayah A Azmi; Nicoletta Sacchi
Journal:  Cell Cycle       Date:  2012-08-30       Impact factor: 4.534

3.  Phase advancing human circadian rhythms with morning bright light, afternoon melatonin, and gradually shifted sleep: can we reduce morning bright-light duration?

Authors:  Stephanie J Crowley; Charmane I Eastman
Journal:  Sleep Med       Date:  2014-12-18       Impact factor: 3.492

Review 4.  Sleep, circadian rhythms and health.

Authors:  Russell G Foster
Journal:  Interface Focus       Date:  2020-04-17       Impact factor: 3.906

5.  Associations among rotating night shift work, sleep and skin cancer in Nurses' Health Study II participants.

Authors:  Carolyn J Heckman; Jacqueline D Kloss; Diane Feskanich; Elizabeth Culnan; Eva S Schernhammer
Journal:  Occup Environ Med       Date:  2016-09-23       Impact factor: 4.402

6.  Disturbance of circadian gene expression in breast cancer.

Authors:  Shou-Jen Kuo; Shou-Tung Chen; Kun-Tu Yeh; Ming-Feng Hou; Ya-Sian Chang; Nicholas C Hsu; Jan-Gowth Chang
Journal:  Virchows Arch       Date:  2009-03-19       Impact factor: 4.064

7.  Circadian rhythm and its role in malignancy.

Authors:  Sobia Rana; Saqib Mahmood
Journal:  J Circadian Rhythms       Date:  2010-03-31

8.  Experimental 'jet lag' inhibits adult neurogenesis and produces long-term cognitive deficits in female hamsters.

Authors:  Erin M Gibson; Connie Wang; Stephanie Tjho; Neera Khattar; Lance J Kriegsfeld
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

Review 9.  Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures.

Authors:  Olga Golubnitschaja; Manuel Debald; Kristina Yeghiazaryan; Walther Kuhn; Martin Pešta; Vincenzo Costigliola; Godfrey Grech
Journal:  Tumour Biol       Date:  2016-07-22

10.  Melatonin in the afternoons of a gradually advancing sleep schedule enhances the circadian rhythm phase advance.

Authors:  Stephanie J Crowley; Charmane I Eastman
Journal:  Psychopharmacology (Berl)       Date:  2012-09-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.